|
Nu Skin Enterprises, Inc. (NUS): Business Model Canvas [Dec-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Nu Skin Enterprises, Inc. (NUS) Bundle
You're looking at Nu Skin Enterprises, Inc. (NUS) and wondering how this direct-selling stalwart is navigating the digital shift, right? Well, after two decades analyzing these models, I can tell you their current canvas is a fascinating pivot: they're leaning heavily into AI-powered personalized wellness with devices like Prysm iO, while simultaneously driving operational efficiency through Project Accelerate. Honestly, seeing their Q2 2025 Latin America growth jump 107% year-over-year while they tighten costs shows a company actively reshaping its core, which is built on over 130,799 paid affiliates as of Q2 2025. Dive into the breakdown below to see exactly how their Key Resources and Revenue Streams are aligning with this new, tech-infused direct-to-consumer strategy.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Key Partnerships
You're looking at the core relationships that power Nu Skin Enterprises, Inc.'s global operations as of late 2025. These aren't just vendors; they are essential components for sales, technology, and product development.
The foundation of the sales engine relies heavily on its global network. As of Q2 2025, this network comprised 130,799 paid affiliates, the individuals driving direct sales and social commerce activities worldwide.
For its digital backbone, Nu Skin Enterprises, Inc. has partnered with Infosys. This collaboration centers on deploying Infosys Equinox, which serves as Nu Skin's NextGen eCommerce Platform. This partnership covers a suite of critical IT services, moving the company toward a digital-first experience.
- Platform Deployment: Rollout of Infosys Equinox, an end-to-end digital commerce and marketing platform.
- Service Scope: Includes application development and support, IT infrastructure management, and IT security operations.
- Goal: To deliver seamless, secure, and highly personalized digital commerce experiences across touchpoints like websites and mobile apps.
Supply chain control and manufacturing leverage the internal capabilities of Rhyz Inc., which is Nu Skin Enterprises, Inc.'s strategic investment arm. Rhyz Inc. includes technology and manufacturing entities that support the core business and external clients.
| Entity Role | Key Metric/Detail |
| US Manufacturing Base | Operates manufacturing facilities in the United States. |
| China Expansion | Invested approximately USD 55 million in a new 440,000 sq ft Shanghai facility. |
| Capacity Impact | The China facility is expected to quadruple production capacity in that region. |
| Third-Party Services | Rhyz manufacturers provide services for 120 other customers outside the core Nu Skin business. |
Scientific validation is a major partnership area, supporting the ageLOC brand. Nu Skin Enterprises, Inc. emphasizes its commitment to innovation through external scientific collaboration.
- Research Foundation: The company's product development is backed by 40 years of scientific research as of 2025.
- Key Academic Link: The company has worked with Stanford University since 1999 on anti-aging and dermatological research.
- Exclusive Access: Partnership with LifeGen Technologies provides access to over 30 years of genetic research into the basis of aging.
Honestly, that 40-year figure is a powerful statement about their long-term R&D commitment. Finance: review the Q3 2025 capital expenditure plan for Rhyz Inc. by next Tuesday.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Key Activities
You're looking at the core actions Nu Skin Enterprises, Inc. (NUS) must execute to deliver its value proposition in late 2025. It's a mix of science, global logistics, and digital transformation.
Research and development of ageLOC and Pharmanex science-backed products
The science backbone is critical for the ageLOC and Pharmanex lines. Nu Skin Enterprises, Inc. is actively using its accumulated data to power new innovations. The company has amassed one of the world's largest antioxidant databases, with over 20 million scans across more than 50 countries. This data feeds the AI engine for new product development, such as the Prysm iO device. The company also emphasizes the entrepreneurial opportunity, having surpassed $20 billion in sales compensation paid to its sales force.
Global operations and logistics across nearly 50 international markets
Maintaining a vast global footprint is a constant key activity. Nu Skin Enterprises, Inc. operates in nearly 50 markets worldwide. The focus in 2025 has been on optimizing this network and accelerating growth in developing regions. For example, the Latin America region showed exceptional growth, up 107% year-over-year in Q2 2025, and maintained double-digit growth in Q3 2025. The company is also executing pre-market opening activities in India during Q4 2025, ahead of a formal launch in the second half of 2026. A major operational goal is to optimize the global product portfolio by over 50% by the end of 2025.
Digital platform development (Vera/Stela apps) for affiliate-powered social commerce
Driving the shift to social commerce requires continuous digital platform support. The Vera app is designed to give customers insights into their beauty and wellness journey by connecting to Bluetooth-enabled devices. The Stela app helps affiliates connect with and nurture their teams, including features like the Pay Me Now function for commission transfers. The company has seen success in this area, with the Nu Skin U.S. business increasing by 32% in a prior period, reflecting the adoption of the social commerce model. Since 2021, Nu Skin Enterprises, Inc. has connected its ageLOC LumiSpa iO and other iO devices, accumulating over 28 million treatments from nearly 500,000 devices and over 100 million data points.
Launch and scale of the Prysm iO intelligent wellness device
The introduction of the Prysm iO intelligent wellness device is a major 2025 activity. This device uses patent-pending technology to non-invasively measure micronutrient absorption in the skin. Management is on schedule for a limited sales leader preview in mid-Q4 2025. The plan is to place more than 10,000 Prysm iO units in Q4 2025, with a global launch planned for 2026.
Execution of Project Accelerate for operational efficiency and cost control
Project Accelerate is central to improving profitability, which is showing results in the financial metrics. The initiative drove the Q2 2025 operating margin to 8%, an increase of 260 basis points from the prior year's adjusted operating margin of 5.4%. Selling expense as a percentage of revenue fell to 33.2% in Q2 2025. In Q3 2025, the operating margin was 5.9%, up from 4.2% in Q3 2024, with selling expenses declining from 39.0% to 35.8%. General and administrative expenses were down $11.2 million in Q2 2025 compared to Q2 2024. The goal is to bring every global market to profitability targets by 2025.
Here's a quick look at the operational performance metrics tied to these activities:
| Metric | Q2 2025 Value | Q3 2025 Value | Comparison/Target |
| Operating Margin | 8% | 5.9% | Up 260 bps YoY in Q2 |
| Selling Expense (% of Revenue) | 33.2% | 35.8% | Down from 39.0% in Q3 2024 |
| Cash Balance | $264 million (Net Cash Position) | $252 million | Positive net cash position achieved ahead of schedule |
| Prysm iO Units Placed (Q4 Target) | N/A | More than 10,000 | Limited preview in late Q4 2025 |
| Markets Operated In | Nearly 50 | Nearly 50 | Goal to bring all to profitability by 2025 |
The digital ecosystem has connected over 500,000 devices since 2021.
- Vera app supports customer beauty and wellness journey insights.
- Stela app enables affiliate team nurturing and commission access.
- Antioxidant database contains over 20 million scans.
- Product portfolio optimization target is over 50% reduction by end of 2025.
Finance: review the Q4 2025 cash flow forecast incorporating Prysm iO initial inventory costs by next Tuesday.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Key Resources
You're looking at the core assets Nu Skin Enterprises, Inc. (NUS) relies on to run its business as of late 2025. These aren't just things they own; they are the engine for their value creation.
The intellectual property underpinning the ageLOC and Pharmanex lines is a massive resource. This is built on a deep scientific foundation, evidenced by the company being ranked the World's No. 1 Company for Beauty and Wellness Device Systems for the second consecutive year. Furthermore, the newest digital push, the Prysm iO intelligent wellness platform, is built on over 20 years of scientific studies and R&D.
Scientific capability is centralized in their physical assets. Nu Skin Enterprises, Inc. operates 11 state-of-the-art R&D labs across key innovation centers. These labs are staffed by a dedicated team of 75 in-house scientists who work alongside an external network of over 150 world-class scientists.
The manufacturing arm, Rhyz Inc., provides essential operational backbone. This segment showed significant momentum, with its Manufacturing division achieving 17% year-over-year revenue growth in the second quarter of 2025. This internal capability helps control quality and supply for their product lines.
The digital ecosystem is rapidly evolving, centered now on the upcoming launch of the Prysm iO device, which features a connected app. This platform is designed to enhance consumer relationships through personalized recommendations, a key part of their future strategy.
Financially, the company maintains a strong position to fund these resources and initiatives. As of the third quarter of 2025, Nu Skin Enterprises, Inc. reported a cash balance of $251.8 million in cash and cash equivalents. This liquidity, combined with a reduction in long-term debt, strengthens the balance sheet.
Here's a quick look at the quantitative resources we've identified:
| Key Resource Category | Specific Metric/Asset | Value/Amount (2025 Data) |
| Financial Strength | Cash and Cash Equivalents (Q3 2025) | $251.8 million |
| Manufacturing & Operations | Rhyz Manufacturing Revenue Growth (Q2 2025 YoY) | 17% |
| R&D Infrastructure | State-of-the-Art R&D Labs | 11 |
| R&D Personnel | In-House Scientists | 75 |
| Intellectual Property/Market Standing | Device System Ranking (Consecutive Years) | 2 |
You can see the commitment to science through the physical labs and the personnel count. Also, note the balance sheet strength; having $251.8 million in the bank heading into the end of the year gives them flexibility.
The digital assets are moving toward the Prysm iO launch, which management sees as a major milestone. This platform leverages years of prior work, which is a testament to the sustained investment in their R&D pipeline.
The key resource areas are:
- Proprietary intellectual property for ageLOC and Pharmanex.
- 11 R&D labs and 75 in-house scientists.
- Rhyz Manufacturing segment growth of 17% in Q2 2025.
- The emerging AI-powered Prysm iO platform.
- Cash reserves of $251.8 million as of Q3 2025.
If onboarding for Prysm iO takes longer than planned, the immediate impact on Q4 revenue guidance might be felt, but the underlying scientific resource base is solid.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Value Propositions
You're looking at the core promises Nu Skin Enterprises, Inc. is making to its customers and affiliates as of late 2025. It's a mix of high-tech personalization, proven science, and the income opportunity that fuels the whole structure.
Personalized Wellness: AI-powered insights from Prysm iO for tailored nutrition/product recommendations.
The push into personalized wellness centers on the upcoming Prysm iO intelligent wellness platform. This system pairs a proprietary health assessment device with an AI-powered insights app. The device quickly and non-invasively measures skin carotenoid levels, giving an immediate indication of a person's overall antioxidant levels and supplement absorption effectiveness. Management expects to place more than 10,000 Prysm iO units in the fourth quarter of 2025, with tens of thousands placed per quarter throughout 2026, aiming to drive subscriptions and higher customer lifetime value. The AI leverages a database built from 20 million scans over 20 years to provide those intelligent lifestyle insights and product recommendations. The limited preview for qualified sales leaders is set for late Q4 2025, with a full consumer launch anticipated in the second half of 2026.
Clinically Proven Anti-Aging: Science-backed products like ageLOC and beauty device systems.
The foundation remains the science behind the ageLOC brand and its accompanying beauty device systems. Nu Skin Enterprises Inc. was ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the second consecutive year as of September 2025. The company's Q3 2025 gross margin for the core Nu Skin business stood at 77.7%, showing sequential improvement, which speaks to the perceived value of these science-backed offerings. The portfolio includes systems like the ageLOC LumiSpa iO, a smart cleansing and treatment device, and the ageLOC WellSpa iO body device. The company is also focusing on portfolio optimization, planning to reduce its global product portfolio by more than 50% by the end of 2025.
Entrepreneurial Opportunity: Dynamic affiliate platform for a social commerce business model.
The dynamic affiliate platform is the engine for social commerce, offering a way for Brand Affiliates to earn compensation. The structure is detailed in the Sales Performance Plan, which rewards affiliates for product sales to Direct Customers and sales by their team members. While the company does not estimate average income from product resales, in 2024, Nu Skin paid approximately $122,224,000 in sales compensation to U.S. Brand Affiliates. As of Q1 2025, the count of Paid Affiliates was 131,518, though this metric saw a 15% year-over-year decline. The company is actively working to revitalize this base, exemplified by strong growth in Latin America, which delivered 53% year-over-year revenue growth in Q3 2025, partly due to strategic pricing and compensation plan enhancements.
Integrated Beauty & Wellness: Comprehensive portfolio of personal care and nutritional supplements.
Nu Skin Enterprises, Inc. offers an integrated approach spanning personal care and nutritional supplements, operating in nearly 50 markets worldwide. The overall company revenue guidance for the full year 2025 is narrowed to $1.48 billion to $1.51 billion. The portfolio is segmented, with the Rhyz segment showing strength; the Rhyz Manufacturing division posted 17% year-over-year revenue growth in Q2 2025. The company is also preparing for a major geographic expansion, with pre-market opening activities in India beginning in Q4 2025 ahead of a formal launch targeted for mid-2026. The Q3 2025 consolidated gross margin was 70.5%, reflecting the mix of these different business lines.
Here's a quick look at the recent financial snapshot grounding these value propositions:
| Metric | Value (Late 2025 Data) |
| Full Year 2025 Revenue Guidance (Low End) | $1.48 billion |
| Q3 2025 Revenue | $364.2 million |
| Q3 2025 Gross Margin (Nu Skin Core) | 77.7% |
| Prysm iO Units Target (Q4 2025) | >10,000 units |
| Latin America YoY Revenue Growth (Q3 2025) | 53% |
| Total Cash Position (End Q3 2025) | $252 million |
The company is definitely focused on driving profitability through operational discipline, with Q3 2025 operating margin reaching 5.9%.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Customer Relationships
Affiliate-Driven Personal Selling: High-touch, personal consultations via the direct sales network.
The core relationship model for Nu Skin Enterprises, Inc. relies heavily on its independent sales leaders and affiliates providing direct, personal engagement with customers. As of the second quarter of 2025, the active network showed a contraction compared to the prior year, reflecting ongoing market pressures.
Here are the key figures from the Q2 2025 reporting period:
| Metric | Q2 2025 Count | Year-over-Year % Change (vs Q2 2024) |
| Total Customers | 771,407 | Down 14% |
| Total Paid Affiliates | 130,799 | Down 16% |
| Total Sales Leaders | 29,593 | Down 23% |
The company is actively focused on strengthening this base through the continued rollout of its enhanced sales performance compensation plan in several markets throughout 2025. The trailing twelve months revenue ending September 30, 2025, stood at $1.56B, a decrease of -12.10% year-over-year.
Digital Self-Service: Use of Vera and Stela apps for product ordering and business management.
Nu Skin Enterprises, Inc. supports its sales network and customers through dedicated digital tools. The Vera and Stela apps serve as primary interfaces for product ordering and business management tasks.
- Vera app provides real-time insights for microcurrent adjustments during device sessions.
- Stela app is used for business management functions by the sales force.
- The upcoming Prysm iO intelligent wellness device, previewed in mid-Q4 2025, utilizes AI capabilities based on a database of 20 million scans over 20 years to provide consumers with intelligent lifestyle insights.
Subscription/Loyalty Programs: Recurring revenue models for nutritional supplements and device consumables.
The digital strategy is directly tied to recurring revenue streams, particularly for consumables related to its beauty and wellness devices. The Prysm iO device is specifically designed to inform recommendations for product subscriptions, aiming to increase customer satisfaction and loyalty.
The company's Q1 2025 revenue was $364.5 million, and the projected full-year 2025 revenue range is between $1.48 billion and $1.55 billion.
Community Building: Global and local events to engage sales leaders and affiliates.
Engagement remains a key relationship driver, supported by both large-scale and local gatherings for its community of affiliates.
Examples of 2025 engagement activities include:
- The One Team Global | System 7 Success Summit held on Sunday, May 25th, 2025.
- The Nu Skin Expo 2025 series, with events scheduled in locations like Perth (September 21st), Auckland (October 11th), Melbourne (October 19th), and Sydney (October 25th).
Finance: draft 13-week cash view by Friday.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Channels
You're looking at how Nu Skin Enterprises, Inc. gets its products and opportunity to the end-user as of late 2025. The core remains the direct selling force, but the digital tools supporting them are increasingly important, especially with the upcoming Prysm iO launch.
The primary channel is the global network of independent brand affiliates, which drives person-to-person marketing and sales. This network is the engine of the direct selling model.
As of the third quarter of 2025, the key metrics for this channel were:
- Total Customers: 746,256
- Total Paid Affiliates: 130,096
- Total Sales Leaders: 31,150
This network operates across a significant physical presence in nearly 50 markets worldwide. Management is actively preparing for expansion into India, with pre-market opening activities starting in the fourth quarter of 2025, ahead of a formal launch in the second half of 2026.
The model is increasingly digital-first, supporting affiliates with technology. This includes company websites and mobile applications designed to simplify operations. For instance, tools like Nu Skin Vera and Nu Skin Stela help affiliates manage their business from their phones. The next major digital channel enhancement is the limited preview of the Prysm iO intelligent wellness platform planned for late Q4 2025. This platform is intended to use AI-powered wellness assessment to drive personalized product recommendations and subscriptions, directly impacting the affiliate's sales channel effectiveness.
Social Commerce is an assumed component, where affiliates leverage social media for sales and recruitment, a common practice in this industry, though specific 2025 financial data tied directly to this sub-channel isn't explicitly broken out in the latest reports. The overall structure relies on affiliates sharing products they love and building communities.
Here is a snapshot comparing the key network components year-over-year based on Q3 2025 results:
| Metric | Q3 2025 Amount | Year-over-Year Change |
| Total Customers | 746,256 | (10)% |
| Total Paid Affiliates | 130,096 | (13)% |
| Total Sales Leaders | 31,150 | (19)% |
| Markets Operated In | Nearly 50 | Consistent |
The channel strategy is clearly focused on digital enablement to support the existing direct selling structure, aiming to reverse the decline in active participants seen through the first nine months of 2025. For example, the full-year 2025 revenue projection sits between $1.48 billion and $1.51 billion, which will be achieved through these channels.
Finance: draft 13-week cash view by Friday.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Customer Segments
You're looking at the core groups Nu Skin Enterprises, Inc. serves as of late 2025. The numbers reflect a period of transition, with operational optimization driving profitability while top-line customer counts adjust. Here's the quick math on the key segments based on the third quarter 2025 data.
Independent Affiliates
This group represents the entrepreneurial backbone of Nu Skin Enterprises, Inc., seeking income through the affiliate opportunity platform. They are the primary sales force promoting the products. As of the third quarter of 2025, the total number of these active participants was 130,096 Paid Affiliates, a 13% year-over-year decline from the 149,264 reported in the third quarter of 2024. Sales Leaders, the top tier of this segment, stood at 31,150 in Q3 2025, down 19% year-over-year. The company is focused on building engagement and alignment within this group for late 2025 initiatives.
Premium Beauty Consumers and Wellness-Focused Individuals
These customers seek science-backed anti-aging skincare devices and nutritional supplements, primarily under the ageLOC and Pharmanex brands. The company is preparing a pivotal launch to stimulate this segment. Nu Skin Enterprises, Inc. is on schedule for a mid-Q4 limited preview of its Prysm iO intelligent wellness device, which is designed to provide personalized product recommendations, especially for nutritional supplements. This AI-powered platform aims to drive customer lifetime value for the wellness-focused buyers. The company has been ranked the World's #1 Company for Beauty and Wellness Device Systems for the second consecutive year as of November 6, 2025.
The overall customer base, which includes both beauty and wellness purchasers, totaled 746,256 as of the third quarter of 2025, representing a 10% year-over-year decrease. If onboarding takes 14+ days, churn risk rises, especially given the macro pressures noted in Greater China and South Korea.
Developing Markets
Geographies outside of established markets are a key focus for returning to growth. Latin America, in particular, has been a significant success story, delivering 107% year-over-year revenue growth in the second quarter of 2025. Nu Skin Enterprises, Inc. is actively leveraging the success principles from this region. Furthermore, the company is on track with its plans for Q4 market pre-opening activities in India, with a formal launch anticipated for mid-2026. The overall 2025 revenue guidance, as narrowed in November 2025, sits between $1.48 billion and $1.51 billion.
Here is a breakdown of the key population metrics as of the third quarter of 2025:
| Segment Metric | Q3 2025 Amount | Q3 2024 Amount | Year-over-Year Change |
|---|---|---|---|
| Total Customers | 746,256 | 831,768 | (10)% |
| Total Paid Affiliates | 130,096 | 149,264 | (13)% |
| Total Sales Leaders | 31,150 | 38,284 | (19)% |
| Americas Customers | 224,013 | Not provided | Not provided |
You can see the concentration of the sales force in the Americas region:
- Americas Paid Affiliates: 28,128
- Americas Sales Leaders: 5,642
- Americas Customers: 224,013
Finance: draft 13-week cash view by Friday.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Cost Structure
When you look at the Cost Structure for Nu Skin Enterprises, Inc. (NUS) as of late 2025, the biggest immediate hit to revenue is the compensation paid to the network. This is the cost of doing business in the direct sales space, and it's significant.
Affiliate Commissions
The compensation plan is the primary driver of selling expenses. For the core Nu Skin business in the second quarter of 2025, Selling Expenses clocked in at 40.0% of revenue, down from 42.2% in the prior year period. By the third quarter of 2025, management reported that the company selling expense fell to 35.8%. This is the cost of rewarding the sales leaders and affiliates for moving product. You'll see this reflected in the Q2 2025 results where total revenue was $386.1 million, and selling expenses were 33.2% overall, but the Nu Skin business portion was 40.0%.
Here's a quick look at the selling expense trend for the core business:
| Reporting Period | Nu Skin Business Selling Expense (% of Revenue) |
| Q2 2024 | 42.2% |
| Q2 2025 | 40.0% |
| Q3 2025 | 35.8% |
Research & Development (R&D)
Nu Skin Enterprises, Inc. continues to invest in product innovation, which is critical for their premium positioning. While I don't have the exact dollar figure for R&D expenses for the latest reported quarters, the ongoing focus is on product launches and preparing for major device rollouts, like the Prysm iO intelligent wellness device previewed in late 4Q25. This investment is a necessary, non-negotiable cost to maintain the value proposition.
Manufacturing and Logistics
Costs related to the global supply chain and manufacturing fall largely under the Rhyz segment. In Q3 2025, the Rhyz segment generated total revenue of $51.6M. Within that, the Manufacturing component accounted for $47.6M of that revenue. To give you a sense of the segment's activity, the Rhyz Manufacturing segment saw revenue growth of 17% year-over-year in Q2 2025.
The structure of these costs involves:
- Costs tied to the Rhyz segment operations.
- Expenses for the global supply chain management.
- Costs associated with product innovation and clinical studies.
General & Administrative (G&A) Expenses
Management has been actively working to streamline overhead, which is evident in their operational optimization efforts. For Q2 2025, General and Administrative Expenses were reported at 27.6% of revenue, an increase from 26.9% in Q2 2024. However, the company has been executing on cost-saving initiatives, including Project Accelerate, which was intended to drive specific expense reductions. You should track the dollar value of G&A expenses against total revenue to see the impact of these ongoing efficiency drives.
The focus on operational efficiency helped the company achieve an 8.0% operating margin in Q2 2025, up from a negative margin in the prior year period.
Finance: draft 13-week cash view by Friday.
Nu Skin Enterprises, Inc. (NUS) - Canvas Business Model: Revenue Streams
You're looking at the income sources for Nu Skin Enterprises, Inc. as of late 2025. The revenue picture is a mix of core product sales, manufacturing services, and a significant one-time event earlier in the year.
The primary engine remains the Sale of Core Nu Skin beauty and wellness products. For the third quarter of 2025, this segment generated revenue of $364.2 million. This figure is reported after excluding the revenue from the Mavely business, which was sold in January 2025.
Another key stream comes from the Rhyz Manufacturing segment, which supports both internal needs and third-party clients. In Q3 2025, total Rhyz revenue hit $51.6 million. Here's the quick math on that segment's Q3 contribution:
| Rhyz Sub-Segment | Q3 2025 Revenue |
|---|---|
| Manufacturing | $47.6 million |
| Rhyz Other | $4.0 million |
| Total Rhyz Revenue | $51.6 million |
The company is also banking on future revenue from its Connected Beauty Device Systems, specifically the upcoming launch of the AI-powered Prysm iO intelligent wellness platform. A limited sales leader preview is scheduled for late Q4 2025, setting the stage for a full consumer launch in 2026. This platform is designed to drive subscriptions and customer lifetime value for their nutritional supplements business.
To give you a broader view of the year's performance leading up to the Q3 report, the revenue for the first nine months of 2025 totaled $1,114.8 million. Looking ahead, Nu Skin Enterprises, Inc. has narrowed its full-year 2025 revenue projection to be between $1.48 billion and $1.51 billion. This compares to the initial full-year forecast of $1.48 billion to $1.55 billion provided earlier in the year.
A significant, non-recurring financial event impacting the overall financial picture was the one-time gain from the sale of the Mavely business in January 2025. This strategic transaction, where the platform was sold for approximately $250 million, generated a reported one-time gain of $176.2 million, which lifted the nine-month net income to $145.7 million. The proceeds from this sale are being used to pay down debt and fund innovation.
You should keep an eye on these key revenue drivers:
- Core Nu Skin product sales performance.
- Growth trajectory of the Rhyz segment.
- Adoption rates for the new Prysm iO device.
- Geographic strength, especially the double-digit growth reported in Latin America.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.